Synthesis and Crystal Structure of N-[2-（4-Chlorophenyl）-1-（1-methylcarbamoyl-2-phenyl-ethylcarbamoyl）-3-phenyl-cyclopropyl]-benzamide

N-[2-(4-chlorophenyl)-1-(1-methylcarbamoyl-2-phenyl-ethylcarbamoyl)-3-phenyl-cyclopropyl]benzamide,C33H30ClN3O3,has been synthesized and characterized by IR,1H NMR,13C NMR and single-crystal X-ray diffraction.The crystal is of triclinic,space group P1 with a = 11.646(2),b = 13.795(3),c = 14.559(3),α = 76.422(4),β = 78.028(4),γ = 74.500(4)°,V = 2164.6(7)3,Z = 3,Mr = 552.05,Dc = 1.270 g/cm3,λ = 0.71073 ,μ(MoKα)= 0.171 mm–1,F(000)= 870,the final R = 0.0469 and wR = 0.0805 for 5554 observed reflections with I > 2σ(I).The N–H and oxygen atoms are involved in one-dimensional intermolecular hydrogen bonds,which further stabilize the structure.     

Synthesis and Crystal Structure of (E)-[1-Ferrocenyl-2-(4-Chlorophenyl) ethylene]

1INTRoDUCTIoNCurrently,thereisaconsiderableinterestintheinvestigationoforganicandorganometallicmaterialsshowinglargenonlinearopticalresponse.Theirpotentialusehasbeenresearchedindeviceapplicationswhicharerelatedtothetelecommuni-cations,opticalcomputingandopticalinformationprocessing"2i.Onamicroscopiclevel,oneofthemajorphysicalparameterstodecidethenonlinearopticalpropertiesofmaterialsisthemolecularhyperpolarizability,avaluedeterminedbyelectronicandgeometricstructureofmolecule.Thetitlecompoun…     

Synthesis and Crystal Structure of Ethyl 3-（4-Chlorophenyl）-3,4-dihydro-6-methyl-4-oxo-2- （pyrrolidin-1-yl）furo[2,3-d]pyrimidine-5-carboxylate

The crystal structure of the title compound ethyl 3-（4-chlorophenyl）-3,4-dihydro-6- methyl-4-oxo-2-（pyrrolidin-1-yl）furo[2,3-d]pyrimidine-5-carboxylate （C20H20ClN3O4, Mr= 401.84） has been prepared and determined by single-crystal X-ray diffraction. The crystal is of monoclinic, space group P21/n with a = 20.6215（9）, b = 8.5311（4）, c = 21.6886（9） A^°, β = 91.607（1）°, V = 3814.0（3）A^°^3, Z = 8, Dc = 1.400 g/cm^3, F（000） = 1680, μ = 0.233 mm^-1, R = 0.0718 and wR = 0.1545 for 6717 observed reflections with I 〉 2σ（I）. X-ray diffraction analysis reveals two crystallographically independent molecules in the asymmetric unit.     

Crystal Structure and Thermal Property of 4-(3-Chlorophenyl)-3-isopropyl-1-methyl-3,4-dihydroquinolin-2(1H)-one

The target compound(C_(19)H_(20)ClNO) was structurally determined by single-crystal X-ray diffraction. The crystal is in monoclinic system, space group P2_1/n with a = 9.2365(2), b = 12.1241(3), c = 14.9960(4) ?, β = 106.589(3)°, C_(19)H_(20)ClNO, M_r = 313.81, D_c = 1.295 g/cm~3, V = 1609.42(7) ?~3, Z = 4, F(000) = 664, μ(MoKa) = 2.097 mm~(-1), T = 200(10) K, 2813 independent reflections with 2533 observed ones(I 2σ(I)), R = 0.0389 and wR = 0.1057 with GOF = 1.043(R = 0.0423 and wR = 0.1083 for all data). The 3,4-dihydroquinolin-2(1 H)-one moiety maintains thermodynamically stable trans configuration. The decomposition mechanism of compound 3 is complex by thermal analysis.     

1-异丙基-3-异丙烯基-1H-吡唑并[3,4-d]嘧啶-4-胺的合成、表征及抗肿瘤活性

以3-碘-1H-吡唑并[3,4-d]嘧啶-4-胺(2)为原料,经过N-烷基化、Suzuki偶联反应得到目标化合物1-异丙基-3-(异丙烯基)-1H-吡唑并[3,4-d]嘧啶-4-胺(1),两步反应总收率57.0 %。产物及中间体结构经₁^H NMR、_1³C NMR、ESI-MS以及X-射线单晶衍射进行表征。并对该Suzuki反应条件进行研究,确定最佳条件为：Pd(dppf)Cl₂的用量为n (Pd(dppf)Cl₂) : n (化合物3) = 0.06 : 1;物料比为n(异丙烯基硼酸): n(化合物3)= 1.6 : 1;反应溶剂为N,N-二甲基甲酰胺;反应温度为100 ℃;反应时间2 h,在最佳反应条件下,该Suzuki偶联反应收率达到68.2 %。体外抗肿瘤活性测试表明,产物(1)对MCF-7、A549、PC-3、HepG2和SGC-7901增殖均有明显的抑制活性,特别抑制MCF-7的IC₅₀值达到10.6 μmol?L_-1^。     

3-(4-氯苯基)-6-取代苯氧乙酰氨基均三唑并[3,4-b]-1,3,4-噻二唑类化合物的合成

将取代苯氧乙酰氨基引入到3,6-二取代均三唑并噻二唑的分子骨架中, 设计合成了8个未见文献报道的3-(4-氯苯基)-6-取代苯氧乙酰氨基均三唑并[3,4-b]-1,3,4-噻二唑类化合物5a～5h, 结构经元素分析、IR和¹H NMR等测试得到确证.     

Synthesis, Crystal Structure and Bioactivities of 1-（4-Chlorophenyl）-3- [ 5-（pyrid-4-yl）- 1,3,4-thiadiazol-2-yl] urea

The title compound 1-(4-chlorophenyl)-3-[5-(pyrid-4-yl)-1,3,4-thiadiazol-2-yl]urea (C14H10ClN5OS, Mr = 331.79) has been synthesized by the reaction of 2-amino-5-(pyrid-4-yl)- 1,3,4-thiadiazole with 4-chlorobenzoyl azide, and its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to triclinic system, space group P with a = 5.8550(8), b = 7.5668(10), c = 16.416(2) , α = 78.364(2), β = 81.204(2), γ = 84.749(2)°, V = 702.58(16) 3, Z = 2, Dc = 1.568 g/cm3, μ = 0.429 mm-1, F(000) = 340, the final R = 0.0442 and wR = 0.1092 for 2001 observed reflections (I > 2σ(I)). X-ray diffraction analysis reveals that the title molecule is nearly planar. In the crystal structure, the molecules are linked by strong intermolecular N-H…N hydrogen bonds together with weak nonclassical intermolecular (C-H…Y, Y = N, O and Cl) hydrogen bonds and stacked through π-π interactions. The preliminary bioassay shows that the title compound exhibits good fungicidal activities against Rhizoctonia solani, Botrytis cinerea and Dothiorella gregaria.